Literature DB >> 17950968

Hemispheric lateralization of bilaterally presented homologous visual and auditory stimuli in normal adults, normal children, and children with central auditory dysfunction.

Teri James Bellis1, Cassie Billiet, Jody Ross.   

Abstract

Two experiments were conducted to examine the performance of normal adults, normal children, and children diagnosed with central auditory dysfunction presumed to involve the interhemispheric pathways on a dichotic digits test in common clinical use for the diagnosis of central auditory processing disorder (CAPD) and its corresponding visual analog. Results of the first experiment revealed a significant right ear advantage (REA) for the dichotic listening task and a left-visual-field advantage (LVFA) for the corresponding visual analog in normal adults and children. In the second experiment, results revealed a significantly larger REA in the children with CAPD as compared to the normal children. Results also revealed a reversed cerebral asymmetry (RVFA) for the children with CAPD on the visual task. Significant cross-modal correlations suggest that the two tasks may reflect, at least in part, similar interhemispheric processing mechanisms in children. Findings are discussed in relation to differential diagnosis and modality-specificity of CAPD.

Entities:  

Mesh:

Year:  2007        PMID: 17950968     DOI: 10.1016/j.bandc.2007.09.006

Source DB:  PubMed          Journal:  Brain Cogn        ISSN: 0278-2626            Impact factor:   2.310


  2 in total

1.  Tinnitus Does Not Interfere with Auditory and Speech Perception.

Authors:  Fan-Gang Zeng; Matthew Richardson; Katie Turner
Journal:  J Neurosci       Date:  2020-06-17       Impact factor: 6.167

2.  Sex differences in microstructural alterations in the corpus callosum tracts in drug-naïve children with ADHD.

Authors:  Qingxia Lin; Xuan Bu; Hong Chen; Yan Liang; Weiqian Wang; Yanhong Yi; Haixi Lin; Lu Lu; Yingxue Gao; Andan Qian; Shuangli Chen; Meihao Wang; Xiaoqi Huang; Chuang Yang
Journal:  Brain Imaging Behav       Date:  2022-01-31       Impact factor: 3.224

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.